Recalcitrant Wet Age-related Macular Degeneration
1 clinical trials · Condition
◉ Watch Recalcitrant Wet Age-related Macular Degeneration
| Record | Firm | Date |
|---|---|---|
| Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept. (NCT01972763) | Northern California Retina Vitreous Associates | 2013-10-01 |
Track Recalcitrant Wet Age-related Macular Degeneration automatically
Every clearance here is in the API, with alerts when new ones post.